Executives Highlight Expansion Plans at the DCAT Member Company Announcement Forum

Senior executives from DCAT Member Companies highlighted their companies’ major news at the DCAT Member Company Announcement Forum at DCAT Week with the latest in expansion plans across the bio/pharmaceutical manufacturing value chain: from drug substances (small-molecules and biologics) to drug products (solid dosage and injectable product forms). Which companies are making the news?

Senior executives from DCAT Member Companies highlighted their companies’ major news at the DCAT Member Company Announcement Forum at DCAT Week with the latest in expansion plans across the bio/pharmaceutical manufacturing value chain: from drug substances (small-molecules and biologics) to drug products (solid dosage and injectable product forms). Which companies are making the news?

Below are the news announcements from companies taking to the podium at the DCAT Member Company Announcement Forum held on March 20, 2023, at DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). A further roundup of other DCAT Member Companies making the news thus far in 2023 will be featured in the April 7, 2023, issue of DCAT Value Chain Insights.

Recent Feature Articles

DCAT Week 2025: Pharma Industry Outlook: Is There Growth or Not?

By
How did the bio/pharma industry perform in 2024, and what is the outlook for 2025 and near term?  What are the key growth areas and what headwinds and tailwinds does the industry face? How will new modalities factor into the growth prospects? Industry experts at DCAT Week 2025 provide the answers.

DCAT Week 2025: Manufacturing, Metrics, & the Supply Chain

By
How are bio/pharma companies and their suppliers tackling difficult challenges in development, manufacturing, and the supply chain, including in risk management? How is supplier relationship management evolving? Senior executives at the education programs at DCAT Week will provide key insights.

CDMO/CMO Outlook: Fill-Finish: A Capacity Crunch or Capacity Easing? 

By
What is the supply-demand outlook for fill–finish capacity in the CDMO/CMO sector? Is a capacity crunch or capacity easing in the making?

DCAT Week 2025: Achieving Supply Chain Resiliency Amid Geopolitical Risk

By
Evolving trade-related issues, such as tariffs, is one of many external variables that factor into the calculus in risk management. An executive panel at an upcoming DCAT Week program will provide perspectives on approaches to best identify, respond, and mitigate risk arising from geopolitical and other external events.